Insider: BROWN MICHAEL S Director - REGENERON PHARMACEUTICALS INC
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 1,382 | 6,162 | 7,544 |
| Value | $772,413.62 | $3,444,003.42 | $4,216,417.04 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 06/14/2024 | DDS | 1,535 | Direct | COM | $1,040.00 | $1,596,400.00 | 1,382 |
| 05/28/2024 | DDS | 1,172 | Direct | COM | $974.86 | $1,142,535.92 | 1,382 |
| 12/27/2023 | DDS | 2,049 | Direct | COM | $898.00 | $1,840,002.00 | 1,247 |
| 04/21/2023 | DDS | 3,070 | Direct | COM | $798.42 | $2,451,149.40 | 1,247 |
| 02/06/2023 | DDS | 500 | Indirect | COM | $797.00 | $398,500.00 | 6,162 |
| 02/06/2023 | DDS | 3,071 | Direct | COM | $798.00 | $2,450,658.00 | 1,247 |
| 01/27/2023 | DDS | 1 | Direct | COM | $747.00 | $747.00 | 1,247 |
| 01/06/2023 | DDS | 3,070 | Direct | COM | $747.14 | $2,293,719.80 | 1,247 |
| 11/08/2022 | DDS | 200 | Direct | COM | $754.70 | $150,940.00 | 2,484 |
| 11/08/2022 | DDS | 200 | Direct | COM | $760.70 | $152,140.00 | 2,284 |
| 11/08/2022 | DDS | 300 | Direct | COM | $753.66 | $226,098.00 | 2,684 |
| 11/08/2022 | DDS | 203 | Direct | COM | $752.14 | $152,684.42 | 2,984 |
| 11/08/2022 | DDS | 126 | Direct | COM | $751.23 | $94,654.98 | 3,187 |
| 11/08/2022 | DDS | 100 | Direct | COM | $761.53 | $76,153.00 | 2,184 |
| 11/08/2022 | DDS | 1,764 | Direct | COM | $748.48 | $1,320,318.72 | 1,749 |
| 11/08/2022 | DDS | 201 | Direct | COM | $767.25 | $154,217.25 | 1,282 |
| 11/08/2022 | DDS | 200 | Direct | COM | $768.11 | $153,622.00 | 1,082 |
| 11/08/2022 | DDS | 500 | Indirect | COM | $748.49 | $374,245.00 | 6,662 |
| 11/08/2022 | DDS | 201 | Direct | COM | $766.74 | $154,114.74 | 1,483 |
| 11/08/2022 | DDS | 100 | Direct | COM | $765.19 | $76,519.00 | 1,684 |
| 11/08/2022 | DDS | 200 | Direct | COM | $764.23 | $152,846.00 | 1,784 |
| 11/08/2022 | DDS | 200 | Direct | COM | $763.19 | $152,638.00 | 1,984 |
| 03/30/2022 | DDS | 408 | Direct | COM | $699.00 | $285,192.00 | 1,082 |
| 03/29/2022 | DDS | 1,522 | Direct | COM | $699.00 | $1,063,878.00 | 1,082 |
| 02/23/2022 | DDS | 500 | Indirect | COM | $608.68 | $304,340.00 | 7,162 |
| 1 2 3 4 5 6 7 8 Next Last You are at page 1 of 8 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research